ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2602

Reduced Frequencies Of Circulating CD8 T Cells In Early Diffuse Cutaneous Systemic Sclerosis Is Associated With Worse Skin Scores

Marie Hudson1, Maximilien Lora2, Christopher Di Ioia3, Solene Tatibouet4, Sasha Bernatsky5 and Ines Colmegna6, 1Rheumatology, Lady David Institute for Medical Research and Jewish General Hospital, Montreal, QC, Canada, 2Rheumatology, McGill University Health Centre, Montréal, QC, Canada, 3McGill University, Montreal, QC, Canada, 4Jewish General Hospital, McGill University, Montreal, QC, Canada, 5Division of Clinical Epidemiology, McGill University Health Center, Montreal, QC, Canada, 6Rheumatology, McGill University Health Centre, Montreal, QC, Canada

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: CD T cells, severity, skin and systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Sclerosis, Fibrosing Syndromes, and Raynaud’s - Clinical Aspects and Therapeutics II

Session Type: Abstract Submissions (ACR)

Background/Purpose: Diffuse cutaneous systemic sclerosis (dcSSc) is associated with significant morbidity and mortality. Measurement of skin thickness (modified Rodnan skin score (mRss)) is a surrogate of dcSSc severity as an increase in this score is associated with involvement of internal organs and increased mortality. Recent studies have found that high levels of the profibrotic type-2 cytokine IL-13 are produced by peripheral blood effector CD8+ T cells from SSc patients and that IL-13-producing circulating CD8+ T cells express skin-homing receptors and induce a profibrotic phenotype in normal dermal fibroblasts. Although one study describes a reduction of the circulating CD8+ T cell subset in dcSSc, the clinical implications of this finding are unknown.

Methods: The frequencies of circulating CD4, CD8, CD20 and CD14 cells were determined by multi-parameter fluorescence-activated cell sorting (FACS) in peripheral blood mononuclear cells isolated from newly diagnosed, untreated dcSSc patients. Samples from patients with early onset, untreated seropositive rheumatoid arthritis were tested as controls. Clinical parameters recorded at the time of sample collection included: mRss, global assessment of activity, global assessment of severity, forced vital capacity and DLCO.

Results: Percentages and absolute counts of cell subsets isolated from dcSSc patients (n=10) with a mean age of 58±8.24 years and a mean disease duration of 2.7±1.8 years were compared with age matched early onset RA patients (n=10). The frequencies of the studied cell subpopulations was similar between RA and dcSSc except for the absolute number and percentage of the CD8+ fraction, which was lower among dcSSc (p=.007 and .03, respectively). Lower frequencies of CD8+ T cells were associated with higher mRss and higher global assessments of activity (p=.0037 and .0052, respectively). For an increase of 1 unit in the mRSS score (range 0-51) there was a decrease of 0.79 in absolute CD8+ T cells and for an increase of 1 unit in the global assessment of activity (range 0-10), there was a decrease of 0.75 in absolute CD8+ T cells.

Conclusion: Our findings suggest that early dcSSc have lower frequencies of peripheral blood circulating CD8+ T cells and that those are inversely associated with skin scores and disease activity. These findings are particularly relevant in light of recent evidence suggesting that skin homing – relocation IL-13-producing CD8+ T cells are directly involved in modulating dermal fibrosis in SSc, and emphasizes the need to prospectively assess the utility of reduced CD8+ T cell frequencies as a biomarker of dcSSc severity.


Disclosure:

M. Hudson,
None;

M. Lora,
None;

C. Di Ioia,
None;

S. Tatibouet,
None;

S. Bernatsky,
None;

I. Colmegna,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/reduced-frequencies-of-circulating-cd8-t-cells-in-early-diffuse-cutaneous-systemic-sclerosis-is-associated-with-worse-skin-scores/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology